The oral antiviral drug molnupiravir by Merck & Co.
Infections
Posted inInfections, Pharma & Biotech
HIV Treatment: One Pill Once a Week
Lenacapavir plus islatravir is a new level of highly active antiretroviral therapy for human immunodeficiency virus infection. Gilead Sciences and Merck & Co. continue their in-depth scientific research.
Posted inCOVID-19, Infections, Research
Famotidine for Treatment of COVID-19: Hope or Hype? The Most Comprehensive Review
Can a popular heartburn drug Pepcid help fight SARS-CoV-2?